Published in Int J Obes (Lond) on August 27, 2015
MiRNA-Mediated Macrophage Polarization and its Potential Role in the Regulation of Inflammatory Response. Shock (2016) 0.86
Circulating MicroRNAs as Potential Biomarkers of Exercise Response. Int J Mol Sci (2016) 0.79
MicroRNAs as paracrine signaling mediators in cancers and metabolic diseases. Best Pract Res Clin Endocrinol Metab (2016) 0.78
MicroRNAs-Dependent Regulation of PPARs in Metabolic Diseases and Cancers. PPAR Res (2017) 0.78
Modulation of Host miRNAs by Intracellular Bacterial Pathogens. Front Cell Infect Microbiol (2016) 0.78
Circulating microRNAs are deregulated in overweight/obese children: preliminary results of the I.Family study. Genes Nutr (2016) 0.77
Nanoparticle-mediated miR200-b delivery for the treatment of diabetic retinopathy. J Control Release (2016) 0.76
Gender Differences in Adipocyte Metabolism and Liver Cancer Progression. Front Genet (2016) 0.76
Maternal Low-Protein Diet Modulates Glucose Metabolism and Hepatic MicroRNAs Expression in the Early Life of Offspring †. Nutrients (2017) 0.75
A Systematic Study of Dysregulated MicroRNA in Type 2 Diabetes Mellitus. Int J Mol Sci (2017) 0.75
Analysis of the function of microRNA-375 in humans using bioinformatics. Biomed Rep (2017) 0.75
Macroautophagy and Selective Mitophagy Ameliorate Chondrogenic Differentiation Potential in Adipose Stem Cells of Equine Metabolic Syndrome: New Findings in the Field of Progenitor Cells Differentiation. Oxid Med Cell Longev (2016) 0.75
MicroRNAa-155 Deficiency Leads to Decreased Atherosclerosis, Increased White Adipose Tissue Obesity and Nonalcoholic Fatty Liver Disease: A Novel Mouse Model of Obesity Paradox. J Biol Chem (2016) 0.75
An Exercise-Only Intervention in Obese Fathers Restores Glucose and Insulin Regulation in Conjunction with the Rescue of Pancreatic Islet Cell Morphology and MicroRNA Expression in Male Offspring. Nutrients (2017) 0.75
MicroRNAs and Drinking: Association between the Pre-miR-27a rs895819 Polymorphism and Alcohol Consumption in a Mediterranean Population. Int J Mol Sci (2016) 0.75
Developmental pathways to adiposity begin before birth and are influenced by genotype, prenatal environment and epigenome. BMC Med (2017) 0.75
Nutrigenetics and Nutrimiromics of the Circadian System: The Time for Human Health. Int J Mol Sci (2016) 0.75
Role of miRNAs in the pathogenesis and susceptibility of diabetes mellitus. J Hum Genet (2016) 0.75
A novel hypoxia-induced miR-147a regulates cell proliferation through a positive feedback loop of stabilizing HIF-1α. Cancer Biol Ther (2016) 0.75
Potential Role of microRNAs in Cardiovascular Disease: Are They up to Their Hype? Curr Cardiol Rev (2016) 0.75
Downregulated miR-29a/b/c during Contact Inhibition Stage Promote 3T3-L1 Adipogenesis by Targeting DNMT3A. PLoS One (2017) 0.75
Targeting MicroRNA in Cancer Using Plant-Based Proanthocyanidins. Diseases (2016) 0.75
The Impact of Environmental Factors in Influencing Epigenetics Related to Oxidative States in the Cardiovascular System. Oxid Med Cell Longev (2017) 0.75
Microparticle parking and isolation for highly sensitive microRNA detection. Lab Chip (2017) 0.75
Milk's Role as an Epigenetic Regulator in Health and Disease. Diseases (2017) 0.75
Targeting Obesity and Diabetes to Treat Heart Failure with Preserved Ejection Fraction. Front Endocrinol (Lausanne) (2017) 0.75
Role of microRNAs in obesity and obesity-related diseases. Genes Nutr (2017) 0.75
The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell (1993) 64.62
Most mammalian mRNAs are conserved targets of microRNAs. Genome Res (2008) 37.16
Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA (2014) 36.94
Posttranscriptional regulation of the heterochronic gene lin-14 by lin-4 mediates temporal pattern formation in C. elegans. Cell (1993) 33.79
Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A (2008) 33.65
Inflammation and metabolic disorders. Nature (2006) 33.33
Origins and Mechanisms of miRNAs and siRNAs. Cell (2009) 20.77
Conservation of the sequence and temporal expression of let-7 heterochronic regulatory RNA. Nature (2000) 19.15
Inflammation and insulin resistance. J Clin Invest (2006) 18.76
Inflammation, stress, and diabetes. J Clin Invest (2005) 17.11
The widespread regulation of microRNA biogenesis, function and decay. Nat Rev Genet (2010) 15.87
A pancreatic islet-specific microRNA regulates insulin secretion. Nature (2004) 15.02
miR-122 regulation of lipid metabolism revealed by in vivo antisense targeting. Cell Metab (2006) 12.41
Many roads to maturity: microRNA biogenesis pathways and their regulation. Nat Cell Biol (2009) 11.50
LNA-mediated microRNA silencing in non-human primates. Nature (2008) 11.45
Local and systemic insulin resistance resulting from hepatic activation of IKK-beta and NF-kappaB. Nat Med (2005) 10.88
Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc Natl Acad Sci U S A (2011) 10.56
miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature (2009) 10.26
Application of massively parallel sequencing to microRNA profiling and discovery in human embryonic stem cells. Genome Res (2008) 10.18
IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance. Science (1996) 8.57
miRWalk--database: prediction of possible miRNA binding sites by "walking" the genes of three genomes. J Biomed Inform (2011) 8.50
MicroRNAs are transported in plasma and delivered to recipient cells by high-density lipoproteins. Nat Cell Biol (2011) 8.21
Modulation of microRNA processing and expression through RNA editing by ADAR deaminases. Nat Struct Mol Biol (2005) 7.49
MiR-33 contributes to the regulation of cholesterol homeostasis. Science (2010) 6.93
The microRNA spectrum in 12 body fluids. Clin Chem (2010) 6.82
MicroRNA-143 regulates adipocyte differentiation. J Biol Chem (2004) 6.78
Widespread A-to-I RNA editing of Alu-containing mRNAs in the human transcriptome. PLoS Biol (2004) 6.67
Circulating microRNAs in patients with coronary artery disease. Circ Res (2010) 6.28
MicroRNA control of signal transduction. Nat Rev Mol Cell Biol (2010) 5.74
Plasma microRNA profiling reveals loss of endothelial miR-126 and other microRNAs in type 2 diabetes. Circ Res (2010) 5.08
Silencing of microRNA families by seed-targeting tiny LNAs. Nat Genet (2011) 4.81
Macrophage-mediated inflammation in metabolic disease. Nat Rev Immunol (2011) 4.68
The Lin28/let-7 axis regulates glucose metabolism. Cell (2011) 4.65
RNA editing of a miRNA precursor. RNA (2004) 4.43
Inhibition of miR-33a/b in non-human primates raises plasma HDL and lowers VLDL triglycerides. Nature (2011) 4.34
Antagonism of miR-33 in mice promotes reverse cholesterol transport and regression of atherosclerosis. J Clin Invest (2011) 4.21
miRTarBase update 2014: an information resource for experimentally validated miRNA-target interactions. Nucleic Acids Res (2013) 4.19
Obesity is associated with hypothalamic injury in rodents and humans. J Clin Invest (2011) 4.17
MicroRNAs 103 and 107 regulate insulin sensitivity. Nature (2011) 3.98
miR-375 maintains normal pancreatic alpha- and beta-cell mass. Proc Natl Acad Sci U S A (2009) 3.89
MicroRNAs in metabolism and metabolic disorders. Nat Rev Mol Cell Biol (2012) 3.78
Functions and mechanisms of RNA editing. Annu Rev Genet (2000) 3.14
MicroRNAs induced during adipogenesis that accelerate fat cell development are downregulated in obesity. Diabetes (2009) 3.02
Tumor necrosis factor-alpha suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates. J Biol Chem (1993) 2.94
MicroRNA-29 regulates T-box transcription factors and interferon-γ production in helper T cells. Immunity (2011) 2.71
Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol (2007) 2.61
Evaluation of quantitative miRNA expression platforms in the microRNA quality control (miRQC) study. Nat Methods (2014) 2.58
Developing microRNA therapeutics. Circ Res (2012) 2.58
A novel regulator of macrophage activation: miR-223 in obesity-associated adipose tissue inflammation. Circulation (2012) 2.55
Obesity-induced overexpression of miRNA-143 inhibits insulin-stimulated AKT activation and impairs glucose metabolism. Nat Cell Biol (2011) 2.38
Control of glucose homeostasis and insulin sensitivity by the Let-7 family of microRNAs. Proc Natl Acad Sci U S A (2011) 2.21
Obesity-induced overexpression of miR-802 impairs glucose metabolism through silencing of Hnf1b. Nature (2013) 2.19
Inhibition of microRNA function by antimiR oligonucleotides. Silence (2012) 2.02
Significance of serum microRNAs in pre-diabetes and newly diagnosed type 2 diabetes: a clinical study. Acta Diabetol (2010) 2.01
MicroRNA and 3T3-L1 pre-adipocyte differentiation. RNA (2006) 2.00
Adipose tissue macrophages promote myelopoiesis and monocytosis in obesity. Cell Metab (2014) 1.96
Statistical evaluation of a biomarker. Anesthesiology (2010) 1.95
Targeting the circulating microRNA signature of obesity. Clin Chem (2013) 1.95
MicroRNAs modulate the noncanonical transcription factor NF-kappaB pathway by regulating expression of the kinase IKKalpha during macrophage differentiation. Nat Immunol (2010) 1.87
Profiling of circulating microRNAs reveals common microRNAs linked to type 2 diabetes that change with insulin sensitization. Diabetes Care (2014) 1.86
MicroRNA expression in human omental and subcutaneous adipose tissue. PLoS One (2009) 1.81
Macrophage microvesicles induce macrophage differentiation and miR-223 transfer. Blood (2012) 1.80
The microRNA miR-8 is a conserved negative regulator of Wnt signaling. Proc Natl Acad Sci U S A (2008) 1.76
miR-130 suppresses adipogenesis by inhibiting peroxisome proliferator-activated receptor gamma expression. Mol Cell Biol (2010) 1.75
Evolutionary conservation of microRNA regulatory circuits: an examination of microRNA gene complexity and conserved microRNA-target interactions through metazoan phylogeny. DNA Cell Biol (2007) 1.75
Cutting edge: miR-223 and EBV miR-BART15 regulate the NLRP3 inflammasome and IL-1β production. J Immunol (2012) 1.71
MicroRNA let-7 regulates 3T3-L1 adipogenesis. Mol Endocrinol (2009) 1.71
Tumor necrosis factor alpha produces insulin resistance in skeletal muscle by activation of inhibitor kappaB kinase in a p38 MAPK-dependent manner. J Biol Chem (2004) 1.69
A resource for the conditional ablation of microRNAs in the mouse. Cell Rep (2012) 1.66
MicroRNA-223 coordinates cholesterol homeostasis. Proc Natl Acad Sci U S A (2014) 1.66
Insulin-independent regulation of hepatic triglyceride synthesis by fatty acids. Proc Natl Acad Sci U S A (2015) 1.66
Integration of microRNA changes in vivo identifies novel molecular features of muscle insulin resistance in type 2 diabetes. Genome Med (2010) 1.64
ADAR editing in double-stranded UTRs and other noncoding RNA sequences. Trends Biochem Sci (2010) 1.63
Changes in circulating microRNAs are associated with childhood obesity. J Clin Endocrinol Metab (2013) 1.61
Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia (2010) 1.60
MicroRNA-370 controls the expression of microRNA-122 and Cpt1alpha and affects lipid metabolism. J Lipid Res (2010) 1.56
Mouse-human experimental epigenetic analysis unmasks dietary targets and genetic liability for diabetic phenotypes. Cell Metab (2015) 1.52
Epigenetic regulation of the DLK1-MEG3 microRNA cluster in human type 2 diabetic islets. Cell Metab (2013) 1.49
MicroRNA-containing microvesicles regulating inflammation in association with atherosclerotic disease. Cardiovasc Res (2013) 1.49
Unsaturated fatty acids inhibit the expression of tumor suppressor phosphatase and tensin homolog (PTEN) via microRNA-21 up-regulation in hepatocytes. Hepatology (2009) 1.45
Adipose tissue microRNAs as regulators of CCL2 production in human obesity. Diabetes (2012) 1.44
Up-regulated expression of microRNA-143 in association with obesity in adipose tissue of mice fed high-fat diet. Biochem Biophys Res Commun (2008) 1.44
miRandola: extracellular circulating microRNAs database. PLoS One (2012) 1.43
Differential expression of microRNAs in adipose tissue after long-term high-fat diet-induced obesity in mice. PLoS One (2012) 1.41
Serum circulating microRNA profiling for identification of potential type 2 diabetes and obesity biomarkers. PLoS One (2013) 1.24
Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity. Diabetologia (2012) 1.23
Differential miRNA expression in omental adipose tissue and in the circulation of obese patients identifies novel metabolic biomarkers. J Clin Endocrinol Metab (2011) 1.22
miR-17-5p and miR-106a are involved in the balance between osteogenic and adipogenic differentiation of adipose-derived mesenchymal stem cells. Stem Cell Res (2012) 1.14
Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes. Diabetologia (2013) 1.11
MicroRNA 34a inhibits beige and brown fat formation in obesity in part by suppressing adipocyte fibroblast growth factor 21 signaling and SIRT1 function. Mol Cell Biol (2014) 1.09
Imperfect centered miRNA binding sites are common and can mediate repression of target mRNAs. Genome Biol (2014) 1.08
Argonaute2 mediates compensatory expansion of the pancreatic β cell. Cell Metab (2013) 1.08
Long-term therapeutic silencing of miR-33 increases circulating triglyceride levels and hepatic lipid accumulation in mice. EMBO Mol Med (2014) 1.04
Human adipose microRNA-221 is upregulated in obesity and affects fat metabolism downstream of leptin and TNF-α. Diabetologia (2013) 1.03
MicroRNA-155 deficiency results in decreased macrophage inflammation and attenuated atherogenesis in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol (2014) 1.03
TNFα-induced up-regulation of miR-155 inhibits adipogenesis by down-regulating early adipogenic transcription factors. Biochem Biophys Res Commun (2011) 1.02
MiRNA-181a regulates adipogenesis by targeting tumor necrosis factor-α (TNF-α) in the porcine model. PLoS One (2013) 1.02
MicroRNA-29 fine-tunes the expression of key FOXA2-activated lipid metabolism genes and is dysregulated in animal models of insulin resistance and diabetes. Diabetes (2014) 1.01